Miaomiao Gao

ORCID: 0000-0002-2147-9167
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Brain Metastases and Treatment
  • Head and Neck Cancer Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Enzyme Structure and Function
  • Genetic diversity and population structure
  • Advanced Radiotherapy Techniques
  • Genetic Mapping and Diversity in Plants and Animals
  • Cancer Immunotherapy and Biomarkers
  • Enzyme Production and Characterization
  • Bone and Dental Protein Studies
  • Mathematical and Theoretical Epidemiology and Ecology Models
  • Lung Cancer Treatments and Mutations
  • Lanthanide and Transition Metal Complexes
  • Genetic and phenotypic traits in livestock

Henan University of Technology
2025

Tianjin Medical University Cancer Institute and Hospital
2020-2023

Shandong University
2018

Shenyang Agricultural University
2014

Bevacizumab is considered a promising therapy for brain necrosis after radiotherapy, while some patients fail to derive benefit or even worsen. Hence, we developed and validated radiomics model predicting the response bevacizumab in with radiotherapy.A total of 149 (with 194 lesions; 101, 51, 42 training, internal, external validation sets, respectively) receiving were enrolled. In total, 1,301 radiomic features extracted from pretreatment MRI images each lesion. training set, signature was...

10.1158/1078-0432.ccr-20-1264 article EN Clinical Cancer Research 2020-07-29

<h3>BACKGROUND AND PURPOSE:</h3> The differential diagnosis of radionecrosis and tumor recurrence in brain metastases is challenging. We investigated the diagnostic efficiency postcontrast T1 mapping solving this problem. <h3>MATERIALS METHODS:</h3> Between March 2016 June 2017, fifty-six patients with who underwent contrast-enhanced cerebral were recruited for prospective study. findings revealed new enhancement after gamma knife radiosurgery. subjects assigned to groups based on follow-up...

10.3174/ajnr.a5643 article EN cc-by American Journal of Neuroradiology 2018-05-03

Abstract Although intravenous bevacizumab (IVBEV) is the most promising treatment for cerebral radiation necrosis (CRN), there no conclusion on optimal dosage. Our retrospective study aimed to compare efficacy and safety of high‐dose with low‐dose IVBEV in treating CRN associated radiotherapy brain metastases (BMs). This paper describes 75 patients who were diagnosed secondary BMs, treated or followed up a minimum 6 months. The clinical data collected this include changes MRI, symptoms,...

10.1111/cas.16053 article EN cc-by-nc-nd Cancer Science 2023-12-25

With the aging of population and increased importance lung cancer screening, number early-stage patients has been on rise in recent years, which can be classified into operable inoperable cancer. The most common pathological type is non-small cell (NSCLC). Stereotactic body radiation therapy (SBRT) optimal treatment for NSCLC. aim this study was to investigate prognosis NSCLC treated with SBRT its influencing factors order reduce side effects radiotherapy improve survival quality...

10.3779/j.issn.1009-3419.2023.102.13 article EN PubMed 2023-04-20

Abstract Objective Standard medical treatment for early non‐small cell lung cancer (NSCLC) is surgery; however, stereotactic body radiotherapy (SBRT) can be a viable substitute elderly patients who no longer tolerate or refuse surgery. The unsurpassed care with NSCLC remains inconclusive. We conducted propensity‐score matching analysis to compare the efficacy and side‐effects of SBRT video‐assisted thoracic surgery (VATS) in pathologically‐proven NSCLC. Methods This single‐institution...

10.1002/pro6.1175 article EN cc-by-nc-nd Precision Radiation Oncology 2022-12-01

In this study, we isolated microsatellite DNA from the Huoyan goose genome with magnetic beads.As a result, 150 positive clones were identified, and 148 microsatellites found.Among microsatellites, 69.6% perfect, 17.6% imperfect, rest compound type (12.8%).Twenty primers used to screen 90 individuals 3 populations.Eight loci polymorphic low number of alleles (2 4).The observed expected heterozygosities ranged 0.3556 1 0.2923 0.6868, respectively.All 8 in Hardy-Weinberg equilibrium.These...

10.4238/2014.july.25.10 article EN Genetics and Molecular Research 2014-01-01
Coming Soon ...